Currently, Laurent is head of R&D and Chief Scientific Officer at Pieris where he’s responsible for the preclinical and clinical development of Anticalins®. During his 12 years in the pharmaceutical industry, Laurent has led a number of clinical candidates int…more ›

Currently Head of Clinical Pharmacology in UCB, in the past 25 years I covered different roles in various pharmaceutical industries, including GlaxoSmithKline, Rottapharm, Zambon and Pharmacia-Upjohn. My recent experience was mainly dedicated to CNS drug development fo…more ›

Dr. Richard Buller is the Vice President of Translational Oncology in the Pfizer Oncology Business Unit. His group is responsible for development of biomarker and companion diagnostic clinical strategies as well as proof of mechanism/pharmacology for drug candidates. …more ›

Rolf Burghaus started his scientific education at the Heinrich-Heine University of Düsseldorf in 1990 taking courses in mathematics and physics. He soon specialized in theoretical physics where he got his diploma in late 1995. He continued in the field and got his …more ›

- I have an MSc in Mathematics from the University of Liege, Belgium, and a Masters in Biostatistics from the University of Hasselt, Belgium - I have been working as a statistician at Novartis since 2006, where I first supported phase III and IV trials. I am currently w…more ›

Nigel Dallow is a Director of Clinical Statistics at GlaxoSmithKline supporting the respiratory area. Nigel has vast experience in working in drug development especially in the early phase area having worked at GSK for 17 years. Though his experiences, Nigel has a stron

Borje Darpo is board-certified in cardiology and internal medicine. He has over 12 years of pharmaceutical industry experience, including senior management positions in small, mid-sized and large pharma, as well as in a global CRO. He has led or has been responsible for…more ›

Pilar de la Rocha Mur is currently the Global Monitoring Operations Head of the Asia Pacific & South Africa region at Novartis Asia Pacific Pharmaceuticals, based in Singapore, where she leads clinical operations activities of the region to support the development o…more ›

Dr. Eichenbaum joined Johnson & Johnson Pharmaceutical R&D, LLC (J&J) in 2002. He is a Preclinical Development Leader/Research Fellow in the department of Drug Safety Sciences. He serves on cross-functional compound development teams and is responsible for…more ›

David P. Elder has thirty four years experience within the Pharmaceutical Industry. He is currently a director at GlaxoSmithKline Pharmaceuticals. He obtained a part-time PhD from Edinburgh University in1992 investigating the crystal structure and solid-state chemistr…more ›

‘Professor Colin Garner is currently Principal at Garner Consulting after a long and distinguished career in academic and commercial science. His research activities have been wide ranging including pioneering the field of genetic toxicology for carcinogen / mutagen sc…more ›

Marten Heeringa PhD is clinical pharmacologist by training and currently Associate Scientific Director at Astellas Pharma. In this capacity, he is responsible for creating global clinical pharmacology and exploratory development strategies, with emphasis on translationa…more ›

After spending 8 years in Contract Toxicology and 11 years as a Toxicologist in the Pharmaceutical Industry, I currently work as an Expert Pharmaco-Toxicologist within the Licensing Division of the Medicines and Healthcare products Regulatory Agency (MHRA) in London. My…more ›

Thierry Lavé is Head of Modeling and Simulation, Non Clinical Safety, Hoffmann-La Roche. He received his degree in Pharmacy (1987) and Ph.D. (1992) from the Strasbourg University, France. Thierry has also 5 year of experience working as Internist at the University…more ›

Dr. Mendzelevski received his degree in Medicine and Board Certification in Internal Medicine from the Ben-Gurion University Medical School and Hospital in Beer-Sheva, Israel. He completed a second fellowship, in cardiology, at the Shaare-Zedek Medical Centre and Hebrew…more ›

Malcolm Mitchell is a graduate of Newcastle Medical School, following a decade in the NHS , he joined the pharmaceutical industry over 25 years ago, with positions in Pfizer, NAPP and Lilly. He has been working in clinical pharmacology at Eli Lilly for the past 18 ye…more ›

Ines Paule is a modeling and simulation scientist in the department of Clinical Pharmacology at Actelion Pharmaceuticals in Basel, Switzerland. She obtained a Master’s degree in statistics and mathematics in Life Sciences; her Ph.D. in pharmacometrics (in Lyon, France) …more ›

2005 Board certification as Clinical Pharmacologist Professional Experience (incl. Memberships) 1992 - 1993 Internship (Internal Medicine) 1993 - 1995 Scientist, Clinical Pharmacology, University of Rostock 1995 - 2001 Scientist, Clinical Pharmacology, Schering AG, Be…more ›